OTC Dry Eye Drops Market Size

OTC Dry Eye Drops Market Size

OTC Dry Eye Drops Market size was valued at around USD 3.7 billion in 2023 and is estimated to grow at 7.6% CAGR from 2024 to 2032. The rising incidence of dry eye syndrome is a significant driver for the market.

To get key market trends

  Download Free Sample

Over-the-counter (OTC) dry eye drops are non-prescription eye drops designed to alleviate symptoms associated with dry eye syndrome, a condition characterized by insufficient tear production or poor tear quality, leading to discomfort, irritation, and ocular inflammation. These drops are formulated to provide temporary relief from symptoms such as dryness, burning, itching, redness, and foreign body sensation in the eyes, making them an effective option for ocular inflammation treatment.

For instance, according to the National Institutes of Health (NIH), the global prevalence of dry eye disease was approximately 11.59%. For symptomatic disease, the estimate was 9.12%, among women, while among men, it was approximately 6.8% in 2021. Therefore, this underscores the growing demand for OTC dry eye drops in the market, as individuals seek accessible and effective solutions to manage the symptoms of dry eye syndrome, especially considering its significant prevalence worldwide.

Furthermore, growing awareness and self-care practices, increased screen time and digital device usage, and technological advancements in product formulations, are driving factors for the market growth.